ASTROCYTOMA, GRADE III
Clinical trials for ASTROCYTOMA, GRADE III explained in plain language.
Never miss a new study
Get alerted when new ASTROCYTOMA, GRADE III trials appear
Sign up with your email to follow new studies for ASTROCYTOMA, GRADE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Electric field device shows promise for tough brain tumors
Disease control CompletedThis study tested a wearable device called NOVOTTF-200A in adults with recurrent Grade III anaplastic astrocytoma, a type of brain cancer. The goal was to see if the device could stop tumor growth for at least six months. Only one person enrolled, and the study looked at safety a…
Matched conditions: ASTROCYTOMA, GRADE III
Phase: NA • Sponsor: Daniela A. Bota • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
New drug TG02 shows promise in early brain cancer trial
Disease control CompletedThis early-phase study tested the drug TG02 in 71 patients with aggressive brain tumors (anaplastic astrocytoma or glioblastoma). The goal was to find the safest dose when combined with either radiation or chemotherapy. The study focused on newly diagnosed elderly patients and th…
Matched conditions: ASTROCYTOMA, GRADE III
Phase: PHASE1 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated May 18, 2026 12:03 UTC